Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABT-089 in children with ADHD
NCT00554385Phase 2Terminated
- Sponsor
- Abbott Laboratories
- Start
- Nov 2007
- Primary completion
- Aug 2008
- Countries
- 1
01
Overview
A Phase 2 trial of pozanicline in attention deficit hyperactivity disorder (ADHD), sponsored by Abbott Laboratories. Started Nov 2007; status: terminated.
02
Drugs
pozanicline
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00554385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00554385.